Visus Therapeutics Archives

Visus Therapeutics Appoints Jehan Tamboowalla to Senior Vice President of Business Development and Marketing

He brings over 20 years of experience in business development, marketing, and portfolio strategy in the ophthalmic and pharmaceutical spaces.

Press Releases2 years ago

Visus Therapeutics Appoints World-Renowned Ophthalmologist, Eric D. Donnenfeld, M.D., to Board of Directors

Dr. Donnenfeld brings significant clinical leadership and innovation experience to expand company’s board of directors.

Press Releases2 years ago

Visus Therapeutics Expands Ophthalmic Drug Development Portfolio with Acquisition of ViewPoint Therapeutics’ Assets

Library of ViewPoint drug candidates will accelerate development of novel alpha-crystallin chaperone compounds as a non-surgical treatment for age-related cataracts.

Press Releases3 years ago

Visus Therapeutics Announces Appointment of Julia Williams as Vice President of Clinical and Medical Affairs

Plus, the company also announced the expansion of its Irvine co-headquarters.

Press Releases3 years ago

Visus Appoints Board Chairman and Head of Business Development

The company’s lead investigational candidate is a treatment for presbyopia.

Press Releases3 years ago

Visus Therapeutics Names 2 to Board of Directors

They'll support the company's efforts to expand its pipeline of potential ophthalmic therapies.

Press Releases3 years ago

Visus Therapeutics Expands Ophthalmic Drug Portfolio with Investigational Therapies For Glaucoma and Age-Related Macular Degeneration

It entered into a licensing agreement with Cella Therapeutics.

Headlines3 years ago

Visus Therapeutics Raises $20M in Financing

The round was led by new investor LSP.

Press Releases3 years ago

Visus Therapeutics Announces Executive Leadership Appointments in Operations, Research, Clinical Operations and Intellectual Property

Ophthalmology industry veterans contribute 130+ years of combined experience to support presbyopia development program & pipeline expansion.

Headlines4 years ago

Visus Therapeutics Raises $36M in Financing

The company is developing a once-daily eye drop to correct for presbyopia.

Press Releases4 years ago

Visus Therapeutics Expands Clinical Advisory Board

It has appointed renowned ophthalmologists.

INVISIONMAG.COM

All posts tagged "Visus Therapeutics"

Visus Therapeutics Appoints Jehan Tamboowalla to Senior Vice President of Business Development and Marketing

Visus Therapeutics Appoints World-Renowned Ophthalmologist, Eric D. Donnenfeld, M.D., to Board of Directors

Visus Therapeutics Expands Ophthalmic Drug Development Portfolio with Acquisition of ViewPoint Therapeutics’ Assets

Visus Therapeutics Announces Appointment of Julia Williams as Vice President of Clinical and Medical Affairs

Visus Appoints Board Chairman and Head of Business Development

Visus Therapeutics Names 2 to Board of Directors

Visus Therapeutics Expands Ophthalmic Drug Portfolio with Investigational Therapies For Glaucoma and Age-Related Macular Degeneration

Visus Therapeutics Raises $20M in Financing

Visus Therapeutics Announces Executive Leadership Appointments in Operations, Research, Clinical Operations and Intellectual Property

Visus Therapeutics Raises $36M in Financing

Visus Therapeutics Expands Clinical Advisory Board

Subscribe

BULLETINS

Facebook